Oppenheimer lowers Ares Management target to $140
Oppenheimer analyst Chris Kotowski maintained an Outperform rating on Ares Management but lowered the price target to $140 from $146. Meanwhile, BMO Capital analyst Brennan Hawken maintained a Market Perform rating and raised the price target to $128 from $125.

*this image is generated using AI for illustrative purposes only.
Oppenheimer analyst Chris Kotowski has maintained an Outperform rating on Ares Management while lowering the price target to $140 from $146. The adjustment reflects a revised valuation outlook despite the firm's continued bullish stance on the stock's performance relative to the broader market.
Separately, BMO Capital analyst Brennan Hawken has maintained a Market Perform rating on Ares Management while raising the price target to $128 from $125. This adjustment reflects a modest recalibration of the stock's valuation potential while keeping a neutral stance relative to the broader market.
The following table summarizes the revised rating details from both firms:
| Firm | Rating | Previous Price Target | New Price Target |
|---|---|---|---|
| Oppenheimer | Outperform | $146 | $140 |
| BMO Capital | Market Perform | $125 | $128 |
The Market Perform rating from BMO Capital indicates that the stock is expected to perform in line with the market average over the long term. In contrast, Oppenheimer's Outperform rating suggests a belief that the stock will exceed market performance.
What factors could drive Ares Management's stock to outperform the broader market despite the lowered price target?
How might the divergence in analyst ratings impact investor sentiment toward Ares Management in the short term?
What upcoming earnings or strategic developments could influence future price target adjustments?






























